{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:20:55Z","timestamp":1758475255524,"version":"3.40.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ejca.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T06:45:19Z","timestamp":1489992319000},"page":"197-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-132X","authenticated-orcid":false,"given":"Jacob A.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.P.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Wisnivesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Kang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.02.008_bib1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejca.2017.02.008_bib2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7150\/jca.4502","article-title":"Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis","volume":"3","author":"Tsikitis","year":"2012","journal-title":"J Cancer"},{"key":"10.1016\/j.ejca.2017.02.008_bib3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bpg.2013.01.006","article-title":"Epidemiology of gastroenteropancreatic neuroendocrine tumours","volume":"26","author":"Fraenkel","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.ejca.2017.02.008_bib4","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.02.008_bib5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejca.2017.02.008_bib6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejca.2017.02.008_bib7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jamcollsurg.2007.05.009","article-title":"Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors","volume":"205","author":"Bilimoria","year":"2007","journal-title":"J\u00a0Am Coll Surg"},{"year":"2012","author":"Compton","series-title":"AJCC cancer staging atlas: a companion to the seventh editions of the AJCC cancer staging manual and handbook","key":"10.1016\/j.ejca.2017.02.008_bib8"},{"key":"10.1016\/j.ejca.2017.02.008_bib9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00428-010-0924-6","article-title":"The ENETS and AJCC\/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement","volume":"456","author":"Kl\u00f6ppel","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejca.2017.02.008_bib10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/bjs.6051","article-title":"Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas","volume":"95","author":"Fischer","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2017.02.008_bib11","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1200\/JCO.2011.35.1817","article-title":"Prognostic validity of a novel American Joint Committee on cancer staging classification for pancreatic neuroendocrine tumors","volume":"29","author":"Strosberg","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2017.02.008_bib12","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1002\/cncr.25855","article-title":"Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome","volume":"117","author":"Jann","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.02.008_bib13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/SLA.0b013e31824e6108","article-title":"Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications","volume":"256","author":"Strosberg","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2017.02.008_bib14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/jnci\/djs208","article-title":"TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study","volume":"104","author":"Rindi","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.02.008_bib15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1200\/JCO.2012.44.5924","article-title":"Prognostic validity of the American Joint Committee on cancer staging classification for midgut neuroendocrine tumors","volume":"31","author":"Strosberg","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.02.008_bib16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.1477","article-title":"Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors","author":"Kim","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.02.008_bib17","doi-asserted-by":"publisher","DOI":"10.1159\/000371807","article-title":"Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors","author":"Kim","year":"2015","journal-title":"Neuroendocrinology"},{"unstructured":"Quality Improvement \u2013 About SEER; n.d. https:\/\/seer.cancer.gov\/about\/uses.html. [Accessed 18 January 2017].","key":"10.1016\/j.ejca.2017.02.008_bib18"},{"key":"10.1016\/j.ejca.2017.02.008_bib19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2017.02.008_bib20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2307\/3803155","article-title":"Avoiding pitfalls when using information-theoretic methods","author":"Anderson","year":"2002","journal-title":"J Wildl Manag"},{"year":"2010","author":"Bosman","series-title":"WHO classification of tumours of the digestive system","key":"10.1016\/j.ejca.2017.02.008_bib21"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917307335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917307335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T06:50:44Z","timestamp":1535957444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917307335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":21,"alternative-id":["S0959804917307335"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.02.008","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}